Table 4.
Standardized response mean (SRM) from baseline to 3 months and to 12 months
| Scale | Subscale | 3 month | 12 month | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| Long Form | Short Form | Long Form | Short Form | ||||||||||
| N | SRM | Range# | N | SRM | Range# | N | SRM | Range# | N | SRM | Range# | ||
| PFDI | UDI | 846 | -0.816 | (-0.490, -1.281) | 853 | -0.714 | (-0.556, -1.091) | 737 | -0.876 | (-0.589, -1.265) | 742 | -0.749 | (-0.535, -1.124) |
| POPDI | 849 | -0.829 | (-0.490, -1.450) | 853 | -0.850 | (-0.437, -1.679) | 738 | -0.878 | (-0.433, -1.473) | 742 | -0.931 | (-0.420, -1.682) | |
| CRADI | 826 | -0.531 | (-0.424, -0.738) | 853 | -0.464 | (-0.361, -0.732) | 722 | -0.537 | (-0.398, -0.947) | 742 | -0.460 | (-0.294, -1.087) | |
| PFIQ | UIQ | 835 | -0.563 | (-0.396, -0.751) | 854 | -0.582 | (-0.393, -0.841) | 734 | -0.694 | (-0.599, -0.807) | 743 | -0.702 | (-0.529, -0.797) |
| POPIQ | 833 | -0.424 | (-0.193, -0.663) | 852 | -0.440 | (-0.229, -0.618) | 733 | -0.472 | (-0.213, -0.618) | 743 | -0.485 | (-0.211, -0.645) | |
| CRAIQ | 836 | -0.382 | (-0.322, -0.693) | 855 | -0.367 | (-0.321, -0.680) | 735 | -0.378 | (-0.292, -0.908) | 744 | -0.363 | (-0.268, -0.895) | |
| SF-36/SF-12* | Physical Summary | 840 | 0.147 | (0.022, 0.277) | NA | 726 | 0.258 | (0.084, 0.401) | NA | ||||
| Mental Summary | 840 | 0.115 | (0.041, 0.449) | NA | 726 | 0.137 | (0.106, 0.342) | NA | |||||
#
The range of standardized response mean (SRM) across 4 studies; NA, not applicable
*
SF36 for CARE, Colpocleisis and ATLAS studies & SF-12 for ABBI study are pooled together
N and standardized response mean (SRM) are from pooled sample across 4 studies
For the PFDI and PFIQ (long and short forms), a negative change in score indicates improvement. For the SF-36 or SF-12, a positive change in score indicates improvement